Cancer immunology research

American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR)
ISSN: 23266066, 23266074

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q1
Impact factor
8.1
SJR
3.781
CiteScore
15.6
Categories
Cancer Research
Immunology
Areas
Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Years of issue
2013-2025
journal names
Cancer immunology research
CANCER IMMUNOL RES
Publications
4 213
Citations
90 024
h-index
144
Top-3 citing journals
Frontiers in Immunology
Frontiers in Immunology (5908 citations)
Cancers
Cancers (3554 citations)
Frontiers in Oncology
Frontiers in Oncology (2244 citations)
Top-3 organizations
Top-3 countries
USA (2460 publications)
China (273 publications)
Germany (258 publications)

Most cited in 5 years

Found 
from chars
Publications found: 24792
Corrigendum to ‘OA09.04 Osimertinib with or without SRS for Brain Metastases from EGFRm NSCLC: Pooled Analysis of Two RCTs’ [Journal of Thoracic Oncology Vol. 19 No. 10S (2024) S28]
Ho C., Soon Y.Y., Nichol A., Robledo K., Sahgal A., Pinkham M., Melosky B., Huang Y., Parmar A., Solomon B., Liu M., Tham I.W., Sacher A., Tey J.C., Menjak I., et. al.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC with PD-L1 Expression ≥50%: 5-Year Outcomes of EMPOWER-Lung 1
Kilickap S., Baramidze A., Sezer A., Özgüroğlu M., Gumus M., Bondarenko I., Gogishvili M., Nechaeva M., Schenker M., Cicin I., Fuang H.G., Kulyaba Y., Zyuhal K., Scheusan R., Garassino M.C., et. al.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Gut Microbiota in Advanced Non-small-cell Lung Cancer Receiving Chemo-immunotherapy: An Ancillary Biomarker Study from the Phase III trial JCOG2007 (NIPPON)
Hakozaki T., Tanaka K., Shiraishi Y., Sekino Y., Mitome N., Okuma Y., Aiba T., Utsumi T., Tanizaki J., Azuma K., Hara S., Morita R., Niho S., Yokoyama T., Toyozawa R., et. al.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Selective depletion of CCR8+Treg cells enhances anti-tumor immunity of cytotoxic T cells in lung cancer via dendritic cells
Chen P., Wang H., Tang Z., Shi J., Cheng L., Zhao C., Li X., Zhou C.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Reply to: “AI Technologies for Patients With Immune-Related Adverse Events”
O’Reilly D., O’Leary C., Naidoo J.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
In this issue
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Navigating the Complexity of Cerebral Prophylaxis: A Path Worth Taking?
Ramella S., Fiore M., D’Angelillo R.M.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Reducing pERKs to Break “RAS”istance to Sotorasib
Gray S.G., O’Connor D., Mutti L., Meirson T.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Predictive Biomarker for SCLC Therapeutics: A Broken Promise or a Complex Disease With Missing Links
Chu Q.S.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Enlarging the Reach of Screening and Early Detection of Lung Cancer
Brown M., Myers R., Lam S.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
A Response to the Letter to the Editor: “Reply to Lei Wu et al.”
Kim E.K., Bak M.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Accurate Risk Factors of Cardiotoxicity in Patients With NSCLC Treated With Osimertinib
Wu L., Liu N., Sun M.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0
Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?
Wu P., Li D., Zhang C., Sun N., He J.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 1
Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing
Liu F., Li H.
Q1
Elsevier
Journal of Thoracic Oncology 2025 citations by CoLab: 0

Top-100

Citing journals

1000
2000
3000
4000
5000
6000
Show all (70 more)
1000
2000
3000
4000
5000
6000

Citing publishers

2000
4000
6000
8000
10000
12000
14000
16000
18000
Show all (70 more)
2000
4000
6000
8000
10000
12000
14000
16000
18000

Publishing organizations

20
40
60
80
100
120
140
160
180
200
Show all (70 more)
20
40
60
80
100
120
140
160
180
200

Publishing organizations in 5 years

10
20
30
40
50
60
70
80
90
Show all (70 more)
10
20
30
40
50
60
70
80
90

Publishing countries

500
1000
1500
2000
2500
USA, 2460, 58.39%
China, 273, 6.48%
Germany, 258, 6.12%
United Kingdom, 248, 5.89%
Canada, 159, 3.77%
Japan, 147, 3.49%
France, 145, 3.44%
Italy, 125, 2.97%
Netherlands, 124, 2.94%
Switzerland, 109, 2.59%
Republic of Korea, 103, 2.44%
Australia, 95, 2.25%
Sweden, 63, 1.5%
Belgium, 54, 1.28%
Israel, 53, 1.26%
Spain, 45, 1.07%
Denmark, 32, 0.76%
Austria, 28, 0.66%
Finland, 28, 0.66%
Norway, 26, 0.62%
Singapore, 26, 0.62%
Brazil, 24, 0.57%
India, 24, 0.57%
Czech Republic, 17, 0.4%
Poland, 14, 0.33%
Ireland, 11, 0.26%
Portugal, 10, 0.24%
Russia, 9, 0.21%
Turkey, 9, 0.21%
Argentina, 8, 0.19%
Hungary, 7, 0.17%
Mexico, 7, 0.17%
Saudi Arabia, 7, 0.17%
Greece, 6, 0.14%
Qatar, 6, 0.14%
New Zealand, 6, 0.14%
Thailand, 6, 0.14%
Puerto Rico, 5, 0.12%
Slovenia, 5, 0.12%
Chile, 5, 0.12%
Georgia, 4, 0.09%
Cyprus, 4, 0.09%
Egypt, 3, 0.07%
South Africa, 3, 0.07%
Cuba, 2, 0.05%
Lebanon, 2, 0.05%
Malaysia, 2, 0.05%
UAE, 2, 0.05%
Croatia, 2, 0.05%
Kazakhstan, 1, 0.02%
Estonia, 1, 0.02%
Algeria, 1, 0.02%
Bulgaria, 1, 0.02%
Iran, 1, 0.02%
Cape Verde, 1, 0.02%
Colombia, 1, 0.02%
Côte d'Ivoire, 1, 0.02%
Latvia, 1, 0.02%
Lithuania, 1, 0.02%
Liechtenstein, 1, 0.02%
Luxembourg, 1, 0.02%
Mauritius, 1, 0.02%
Malawi, 1, 0.02%
Mali, 1, 0.02%
Namibia, 1, 0.02%
Nigeria, 1, 0.02%
Cayman Islands, 1, 0.02%
Peru, 1, 0.02%
Slovakia, 1, 0.02%
Uganda, 1, 0.02%
Falkland Islands (Malvinas), 1, 0.02%
Ethiopia, 1, 0.02%
Show all (42 more)
500
1000
1500
2000
2500

Publishing countries in 5 years

100
200
300
400
500
600
700
800
900
1000
USA, 963, 56.05%
China, 162, 9.43%
United Kingdom, 102, 5.94%
Canada, 79, 4.6%
Germany, 73, 4.25%
France, 62, 3.61%
Italy, 49, 2.85%
Switzerland, 49, 2.85%
Japan, 45, 2.62%
Netherlands, 43, 2.5%
Republic of Korea, 43, 2.5%
Australia, 38, 2.21%
Israel, 25, 1.46%
Sweden, 25, 1.46%
Belgium, 22, 1.28%
Spain, 15, 0.87%
Denmark, 13, 0.76%
Finland, 13, 0.76%
Austria, 10, 0.58%
Brazil, 10, 0.58%
India, 10, 0.58%
Singapore, 10, 0.58%
Czech Republic, 10, 0.58%
Ireland, 7, 0.41%
Norway, 7, 0.41%
Turkey, 7, 0.41%
Poland, 6, 0.35%
Portugal, 5, 0.29%
Hungary, 5, 0.29%
Puerto Rico, 5, 0.29%
Russia, 4, 0.23%
Cyprus, 4, 0.23%
Slovenia, 4, 0.23%
Greece, 3, 0.17%
Mexico, 3, 0.17%
Saudi Arabia, 3, 0.17%
Thailand, 3, 0.17%
Argentina, 2, 0.12%
Egypt, 2, 0.12%
New Zealand, 2, 0.12%
Georgia, 1, 0.06%
Iran, 1, 0.06%
Côte d'Ivoire, 1, 0.06%
Lithuania, 1, 0.06%
Luxembourg, 1, 0.06%
Mauritius, 1, 0.06%
Malawi, 1, 0.06%
Mali, 1, 0.06%
Namibia, 1, 0.06%
Nigeria, 1, 0.06%
Peru, 1, 0.06%
Slovakia, 1, 0.06%
Uganda, 1, 0.06%
Croatia, 1, 0.06%
Chile, 1, 0.06%
Ethiopia, 1, 0.06%
South Africa, 1, 0.06%
Show all (27 more)
100
200
300
400
500
600
700
800
900
1000